Bengaluru, India (ots/PRNewswire) - Strong Revenue growth guidance of 13%-15% and operating margin guidance of 21%-23% for FY23 Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $16.3 billion in revenues with the highest annual growth in the last decade of 19.7% in constant currency with a ...
Ashburn, Va and Dublin, Ireland (ots/PRNewswire) - Chirisa Holdings Inc. today announces that 365 Data Centers, a leading hybrid data center and network solutions provider, has been acquired by Stonecourt Capital LP. Chirisa has led the investment in 365 since 2017 alongside CEO Bob DeSantis and co-investors Lumerity Capital, Turning Rock Partners and Longboat Advisors. Over that time, 365 has developed into one of the largest privately-owned operators across the eastern ...
Redmond, Washington and Bengaluru, India (ots/PRNewswire) - Infosys (http://www.infosys.com/) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a collaboration with Microsoft to deliver smart buildings and spaces (SB&S) solutions for the architecture, engineering, ...
Not intended for media in the UK and the U.S. - Company launches global art campaign for people with MS to express their invisible symptoms and the unseen impact of the disease - Thought-provoking campaign coincides with the launch of MSonyourterms.com (http://www.msonmyterms.com/), a resource for patients, carers, and the public to understand MS from the Inside Out - Merck to donate EUR1 to the Multiple Sclerosis ...
Bengaluru, India (ots/PRNewswire) - "We have completed the first year of our transformation journey with strong results on multiple dimensions including revenue growth, performance of our digital portfolio, large deal wins, and client metrics. This is a reflection of our increased client relevance stemming from our focus on digital, positioning, and long-standing ...
Indianapolis (ots/PRNewswire) - A new online, interactive training programme designed to help patient advocates better influence decisions related to access to new medicines was launched today in advance of the 6th Global Patient Congress at Ascot, United Kingdom. Developed by Eli Lilly and Company in collaboration with internationally renowned experts in the fields of ...